梅花生物：8月19日召开董事会会议

Core Viewpoint - Meihua Biological announced the convening of its 20th meeting of the 10th Board of Directors on August 19, 2025, to review the semi-annual report and its summary for 2025 [2]. Group 1: Company Financials - For the year 2024, Meihua Biological's revenue composition is as follows: 97.34% from bio-fermentation, 1.9% from pharmaceutical health, and 0.76% from other businesses [2].